Bone density can be assessed by dual-energy bone densitometry with specific X-rays, CT-based absorptiometry, quantitative ...

Had cash of $33.1M as of December 31, 2024, up from $19.3M at the end of FY23. Anticipates that existing cash reserves and proceeds will be ...

Morgan Stanley has initiated Celldex Therapeutics (NASDAQ:CLDX) at overweight saying that barzolvolimab (barzol), its asset ...

The following is a summary of "Worsening disease severity as measured by I-SEE associates with decreased treatment response ...

Only two cases of chronic hiccups tied to eosinophilic esophagitis have previously been reported, the man's doctors say.

The incidence and prevalence of eosinophilic esophagitis in the United States are higher than previously reported, indicating increased disease burden, according to a poster presented here. EoE can ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Researchers from Revolo Biotherapeutics Ltd. recently presented preclinical data for IRL-201104, a clinical-stage ...

("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company specializing in precision local drug delivery, today announced additional positive clinical data from ...

Histological scores and symptom scores continue to improve as EP-104GI dose, and area of esophageal coverage, increase Cohort 6 showed the greatest symptom relief scores ("SDI") of all cohorts to ...

Cohort 6 showed the greatest symptom relief scores ("SDI") of all cohorts to date at 12 weeks Cohort 6 had the greatest magnitude and percentage change in tissue health scores ("EoEHSS") of any ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.